Report Highlights
Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors
2) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By Administration: Oral; Parenteral
Covering: ViiV Healthcare; Gilead Sciences; Merck & Co., Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)
HIV Drugs Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hiv drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description:
Where is the largest and fastest growing market for hiv drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hiv drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2022 |
| Forecast period considered | 2022-2032 |
| Units considered | $ Billion |
| Segments covered | By Type, By Application, By Administration |
| Industry covered | Pharmaceuticals |
| Regions covered | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Countries covered | Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA |
| Companies studied |
|
Scope
Markets Covered:
- By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors; Other Types
- By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Applications
- By Administration: Oral; Parenteral
Companies Mentioned: ViiV Healthcare; Gilead Sciences; Merck & Co., Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
- Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Table 3 : Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 4 : Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 5 : Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 6 : Global HIV Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 7 : Global HIV Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 8 : Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 9 : China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 10 : India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 11 : Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 12 : Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 13 : Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 14 : South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 15 : Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 16 : UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 17 : Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 18 : France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 19 : Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 20 : Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 21 : North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 22 : USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 23 : South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 24 : Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 25 : Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 26 : Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Table 27 : ViiV Healthcare Financial Performance
- Table 28 : Gilead Sciences Financial Performance
- Table 29 : Merck & Co., Inc. Financial Performance
- Table 30 : Bristol-Myers Squibb Company Financial Performance
- Table 31 : Janssen (Johnson&Johnson) Financial Performance
- Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
- Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
- Figure 3 : Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 4 : Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 5 : Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 6 : Global HIV Drugs Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 7 : Global HIV Drugs Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 8 : Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 9 : China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 10 : India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 11 : Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 12 : Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 13 : Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 14 : South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 15 : Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 16 : UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 17 : Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 18 : France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 19 : Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 20 : Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 21 : North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 22 : USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 23 : South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 24 : Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 25 : Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 26 : Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Figure 27 : ViiV Healthcare Financial Performance
- Figure 28 : Gilead Sciences Financial Performance
- Figure 29 : Merck & Co., Inc. Financial Performance
- Figure 30 : Bristol-Myers Squibb Company Financial Performance
- Figure 31 : Janssen (Johnson&Johnson) Financial Performance
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
HIV Drugs Global Market Report 2022
Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors; Others
2) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Others
3) By Administration: Oral; Parenteral
Covering: ViiV Healthcare; Gilead Sciences; Merck & Co., inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)
HIV Drugs Global Market Report ...
HIV Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth
Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrase strand transfer inhibitors (INSTIs); Others
2) By Application: Hospital Pharmacies; Retail Pharmacies; Others
3) By Administration: Oral; Parenteral
Covering: Gilead Sciences, Inc.; GlaxoSmithKline plc.; Johnson & Johnson; Merck & Co., Inc.; Boehringer Ingelheim International GmbH
HIV Drugs Global Market Opportunities And Strategies ...
HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030
Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors; Others
2) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Others
3) By Administration: Oral; Parenteral
Covering: ViiV Healthcare; Gilead Sciences; Merck & Co., Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)
HIV Drugs Global Market Report ...
HIV Drugs Global Market Report 2020-30: Covid 19 Implications and Growth
Including: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT’s); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors; Others; 2) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Others
Covering: ViiV Healthcare; Gilead Sciences; Merck & Co., Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More